BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15537360)

  • 1. N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters.
    Gardner RA; Delcros JG; Konate F; Breitbeil F; Martin B; Sigman M; Huang M; Phanstiel O
    J Med Chem; 2004 Nov; 47(24):6055-69. PubMed ID: 15537360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters.
    Wang C; Delcros JG; Cannon L; Konate F; Carias H; Biggerstaff J; Gardner RA; Phanstiel IV O
    J Med Chem; 2003 Nov; 46(24):5129-38. PubMed ID: 14613316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates.
    Wang C; Delcros JG; Biggerstaff J; Phanstiel O
    J Med Chem; 2003 Jun; 46(13):2672-82. PubMed ID: 12801231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of dihydromotuporamine derivatives in cells containing active polyamine transporters.
    Kaur N; Delcros JG; Martin B; Phanstiel O
    J Med Chem; 2005 Jun; 48(11):3832-9. PubMed ID: 15916435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of N1-(anthracen-9-ylmethyl)triamines as molecular recognition elements for the polyamine transporter.
    Wang C; Delcros JG; Biggerstaff J; Phanstiel O
    J Med Chem; 2003 Jun; 46(13):2663-71. PubMed ID: 12801230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity investigations of polyamine-anthracene conjugates and their uptake via the polyamine transporter.
    Phanstiel O; Kaur N; Delcros JG
    Amino Acids; 2007 Aug; 33(2):305-13. PubMed ID: 17410331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of chloroambucil- and xylene-containing polyamines leads to improved ligands for accessing the polyamine transport system.
    Kaur N; Delcros JG; Imran J; Khaled A; Chehtane M; Tschammer N; Martin B; Phanstiel O
    J Med Chem; 2008 Mar; 51(5):1393-401. PubMed ID: 18281932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Drosophila model to identify polyamine-drug conjugates that target the polyamine transporter in an intact epithelium.
    Tsen C; Iltis M; Kaur N; Bayer C; Delcros JG; von Kalm L; Phanstiel O
    J Med Chem; 2008 Jan; 51(2):324-30. PubMed ID: 18163550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing the polyamine pharmacophore: influence of N-substituents on the transport behavior of polyamine conjugates.
    Kaur N; Delcros JG; Archer J; Weagraff NZ; Martin B; Phanstiel Iv O
    J Med Chem; 2008 Apr; 51(8):2551-60. PubMed ID: 18363351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines.
    Delcros JG; Tomasi S; Duhieu S; Foucault M; Martin B; Le Roch M; Eifler-Lima V; Renault J; Uriac P
    J Med Chem; 2006 Jan; 49(1):232-45. PubMed ID: 16392808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the polyamine transport system with benzazepine- and azepine-polyamine conjugates.
    Tomasi S; Renault J; Martin B; Duhieu S; Cerec V; Le Roch M; Uriac P; Delcros JG
    J Med Chem; 2010 Nov; 53(21):7647-63. PubMed ID: 20925391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxic activities of usnic acid derivatives.
    Bazin MA; Le Lamer AC; Delcros JG; Rouaud I; Uriac P; Boustie J; Corbel JC; Tomasi S
    Bioorg Med Chem; 2008 Jul; 16(14):6860-6. PubMed ID: 18558490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the preferred shapes of polyamine transporter ligands and dihydromotuporamine-C mimics: shovel versus hoe.
    Breitbeil F; Kaur N; Delcros JG; Martin B; Abboud KA; Phanstiel O
    J Med Chem; 2006 Apr; 49(8):2407-16. PubMed ID: 16610784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents.
    Tian ZY; Xie SQ; Du YW; Ma YF; Zhao J; Gao WY; Wang CJ
    Eur J Med Chem; 2009 Jan; 44(1):393-9. PubMed ID: 18423800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine-iron chelator conjugate.
    Bergeron RJ; McManis JS; Franklin AM; Yao H; Weimar WR
    J Med Chem; 2003 Dec; 46(25):5478-83. PubMed ID: 14640556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of unsymmetrical polyamine derivatives as antitumor agents.
    Wang J; Xie S; Li Y; Guo Y; Ma Y; Zhao J; Phanstiel O; Wang C
    Bioorg Med Chem; 2008 Jul; 16(14):7005-12. PubMed ID: 18539036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endocytosis in the internalization of spermidine-C(2)-BODIPY, a highly fluorescent probe of polyamine transport.
    Soulet D; Covassin L; Kaouass M; Charest-Gaudreault R; Audette M; Poulin R
    Biochem J; 2002 Oct; 367(Pt 2):347-57. PubMed ID: 12097141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,4-disubstituted anthracene antitumor agents.
    Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
    J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine modulation of iron uptake in CHO cells.
    Gaboriau F; Kreder A; Clavreul N; Moulinoux JP; Delcros JG; Lescoat G
    Biochem Pharmacol; 2004 May; 67(9):1629-37. PubMed ID: 15081862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
    Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C
    Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.